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ABSTRACT 
 
With the rapid development in the amount of molecular biological structures, computational molecular docking (CMD) 
approaches become one of the crucial tools in rational drug design (RDD). Currently, number of researchers are working in this 
filed to overcome the recent issues of docking by using genetic algorithm approach. Moreover, Genetic Algorithm facilities the 
researchers and scientists in molecular docking experiments. Since conducting the experiment in the laboratory considered as 
time consuming and costly, the scientists determined to use the computational techniques to simulate their experiments. In this 
paper, auto dock 4.2, well known docking simulation has been used to perform the experiment in specific disease called malaria. 
The genetic algorithm (GA) approach in the autodock4.2 has been used to search for the potential candidate drug in the twenty 
drugs. It shows the great impacts in the results obtained from the CMD simulation. In the experiment, we used falcipain-2 as our 
target protein (2GHU.pdb) obtained from the protein data bank and docked with twenty different available anti malaria drugs in 
order to find the effective and efficient drugs. Drug Diocopeltine A was found as the best lowest binding energy with the value 
of -8.64 Kcal/mol. Thus, it can be selected as the anti malaria drug candidate. 
 
Keywords: Genetic algorithm , drug candidte , rational drug design ,  molecular docking , docking , protein , ligand , computer simulation 
algorithm and computational molecular docking. 
 
1.   INTRODUCTION 
 
 Rational drug design (RDD) is a central paradigm 
in pharmaceutical research. It begins with predefined 
knowledge about specific compound or drug and then 
studies its behavior towards the disease [1]. Drug is known 
as any chemical substance that, when absorbed into body of 
a living organism, alters normal bodily function.  Moreover, 
the drug design is known as the procedure that used to find 
drugs by design through several stages based on their 
biological targets.  The   development of drug design and 
discovery starts by discovering the drug(s) then register it for 
the marketing and commercialization purpose [2]. The drug 
discovery and development is a costly process that includes 
extensive clinical testing. The discovery and designing of  
new drugs involves several phases,  namely as identify the 
disease, isolate the protein  target causing the disease, 
finding the drug, pre-clinical test, clinical phases 1,2 and 3 
and finally FDA1 approval[3]. Fig. 1 summarizes the RDD 
process:   
 
 
 
Fig 1: Drug Design and Discovery Process 
                                                 
1 Stands for Food Drug Administration.   
2. GENETIC ALGORIHM  
 
Genetic Algorithm is a search heuristic that imitate 
the process of natural evolution. Genetic algorithms (GAs) 
are inspired in Darwin's theory of evaluation by natural 
selection and are powerful tool in difficult search and 
optimization problems [4]. Genetic algorithm model the 
solution of the problem into data structure called 
chromosome or genotype which represents the possible 
solutions called individuals or phenotypes. A sequence of 
genetic operators is applied to these chromosomes in order 
to achieve a high optimization of the problem [5]. Two 
components play a significant role in the GA method: the 
problem codification and the evaluation function. The 
problem codification is the mapping that is made between 
the chromosomes and the individuals. Typically, the 
individuals are mapped into a string of 1's and 0's indicating 
the presence, or not of some feature or characteristic as 
shown in Fig.2. The evaluation function takes one individual 
and calculates its fitness. Usually, the fitness is a 
performance measure of the individual as a solution to the 
problem. However, Fig. 3 describes the pseudo-code of 
general genetic algorithm. 
 
 
f0 f1 f2 F3 F4 F5 F6 F7 F8 F9 
1 1 1 0 0 0 0 0 1 0 
 
Fig 2: Chromosome representation in GA 
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Fig 3: Genetic Algorithm Pseudo-Code 
 
 Fig. 4 shows the genetic algorithm flowchart. In 
order to evaluate the optimized solution, it must goes 
through certain specific as stated in the flowchart.    
 
Start 
Randomly Generate initial Population   
Evaluate all Individuals  
Stop?  Best Individuals 
Result Selective Reproduction 
Crossing Over 
Mutation 
Generation Cycle No
Yes
 
 
Fig 4: Genetic Algorithm Flowchart 
 
3. DRUG DESIGN  
 
Drug design is known as approach that uses 
specific tools to explore and search    for candidate drugs by 
design. It is based on their biological targets such as the 
target protein and receptor. Naturally, a drug target is a key 
molecule involved in a particular metabolic or signaling 
pathway that is specific to a disease condition [6]. A number 
of approaches try to stop the functioning of the pathway in 
the diseased state by causing a key molecule to stop 
functioning. Drugs may be designed that bind to the active 
region and inhibit this key molecule. However these drugs 
would also have to be designed in such a way as not to affect 
any other important molecules that may be similar in 
appearance to the key molecules. The structure of the drug 
molecule that can specifically interact with the bimolecular 
(protein) can be modeled using computational tools such as 
Auto dock simulation. These tools can allow a drug 
molecule to be constructed within the bimolecular using 
knowledge of its structure and the nature of its active site. 
Construction of the drug molecule should be made inside the 
programs by combing the two files together in the same 
directory [7]. 
 
4. MOLECULAR DOCKING  
 
Molecular docking is a computer simulation or 
computational tool that uses specific procedures to predicate 
the conformation of a receptor-ligand complex, where the 
receptor is usually a protein and the ligand is either a small 
molecule (drug) or another protein [8]. It is consider as the 
key step in identifying potential drug candidates [9]. In 
addition, it is known as the automated computer algorithm 
that determines how candidate ligands will be docked into 
the active site of the target protein.  It involves several 
processes such as determination of orientation, 
conformational geometry and the scoring function. The real 
task of docking algorithm is to locate the ligand in many 
different orientations and conformations in the active site of 
the selected protein and then calculate the score for each 
ligand docked in the protein. Moreover, docking consider as 
the common tool used in the field of computational drug 
design. It predicates if a selected drug will be a good 
inhibitor of target protein. As a result, pharmaceutical 
companies evaluate and examine a huge numbers of ligands 
using docking technique [10]. The next phase after analyze 
the drugs, the best docking score will be selected as the 
synthesized and it will be test in the laboratory.  
 
5. MOLECULAR DOCKING PROCESS  
 
The process of searching for a ligand that fit to 
protein binding site is called molecular docking [11].It starts 
with finding the proper docking conformation of the drug 
docked into the target protein. It will be elaborated more in 
the techniques used in docking.   The binding mode of the 
ligand with the target receptor can be distinctively defined 
based on its state variables. It encompass of its position(x-, 
y- and z-translation) in the 3D structure, orientation (Euler 
angles, axis-angle, or a quaternion), and if the ligand is 
flexible, its conformation (torsion angles for each rotatable 
bond). Each of these state variables describes one degree of 
freedom (DOF) in a multidimensional search space, and 
their bounds describe the extent of the search. Generally, the 
rigid docking is faster than the flexible ligand due to the size 
of the search space is smaller than the flexible.  
 
6. METHODOLOGY  
 
In this paper we have conducted the experiment on 
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20 drugs to select the best drug candidate. Beside that all 
software(s) used for the analysis is free for academic used. In 
the following we summarize all the sites/software used in this 
project: 
 
a. Protein Data Bank (PDB) 
 
 Protein Data Bank (PDB) is a worldwide repository 
for processing macromolecular structure data.  
 It has more than 25000 structures determined by x-
ray diffraction. 
 Protein structure downloaded from the site with 
particular keywords or numbers. 
 
b. PyMol  
  
 PyMol is Python-based visualization software. 
 Used to visualize the PDB files obtain from RCSB 
database. 
 Measure the distance between atoms. 
 
c. AutoDock 4.2  
 
 Drug discovery tool uses genetic algorithm. 
 It is used to generate all the necessary input files 
and   docking grid.   
 Used to perform the docking experiments in the 
selected drugs and proteins. 
 It is automated docking tools designed to predict 
how small molecules/ligands such as drug 
candidate bind to receptor or protein of known 3D 
structure.    
 Allows users to interact with molecular and 
perform computational experiments easily.  
 Auto dock consists of two separate programs 
namely as Auto Dock and Auto Grid 
 
 Auto dock: used to perform the docking of the ligand 
(drug) to a set of grids describing the target protein.  
 
 Auto Grid: used to pre calaculates these grids.  
 
7. TECHNIQUES USED IN DOCKING  
 
The molecular docking process can be divided in to 
two phases. One is the searching algorithm, which finds 
possible binding geometries of the protein and its ligand 
[12]. The other is the scoring function, which ranks the 
searching results and selects out the best binding geometry 
based on the energies of the complexes. The docking 
software name Autodock4.0 is used for docking [13]. A 
typical docking study requires three computational steps 
before running the docking program which is as the 
following [14]:    
 
1. Preparation of receptor & ligand files. 
 
2. Calculation of affinity maps by using a 3D grid 
around the receptor & ligand.  
 
3. Defining the docking parameters and running the 
docking simulation.  
 
 The following diagram shows the common steps 
involved in the docking process: 
 
 
 
Fig 5: Docking Procedure Chart 
 
 Fig. 5 shows the preparation procedures that 
perform in order to dock the ligands or drugs to the protein 
active site. Now, we will explain the process that involved in 
the docking mechanism starting from downloading the target 
protein till the end of docking and getting the output file in 
the .dlg format which is docked ligand file contains all the 
required information about the ligand such as binding energy 
value, intermolecular value and so on.  
 
8. METHODS AND MATERIALS  
 
 First of all we have to identify the potential target 
disease which is in case of Malaria. The next step is to find 
out the 3D structure for this disease which is 2GHU.pdb; and 
it was retrieved from RCSB database. 
 
Table 1: Protein Selection and Identification 
 
Target Disease Target Protein (PDB) 
Malaria 2GHU.pdb 
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a. Target Selection and Identification  
 
The search for effective, safe, and affordable drugs 
for malaria treatment is an urgent need worldwide [15]. 
Parasite Plasmodium Falciparum develops a special 
organelle comprising a set of proteases to utilize cytosolic 
proteins of the host cell as a food source during its life cycle 
within host red blood cell.  There are several target proteins 
that play a significant role in life cycle of Plasmodium 
Falciparum. These proteins target have been well studied 
and then validated for their significance survival as well as 
their “drug-ability” [16] .Moreover, with the sequencing of 
the Plasmodium genome several new potential targets came 
into light. These potential antimalarial drug targets including 
targets involved in hemoglobin degradation. This protease 
contains plasmepsins and falcipains and they have been 
treated as potential drug targets [17]. 
 
b. Ligand (Drug) Identification  
 
Once the therapeutic target has been identified, we 
must then find one or more Drugs (e.g., chemical 
compounds or molecules) that interact with the therapeutic 
target so as to induce the desired therapeutic effect, e.g., 
through antiviral or antibacterial activity. In order to 
discover the ligands (Drugs) whose pharmacological 
properties are likely to have the required therapeutic effects, 
researchers must test a large variety of them on one or more 
targets. However, in this paper we retrieved the ligands from 
pubchem chemical database. All the compounds were in .sdf 
format and then we convert it into .pdb format for ligands. 
The conversion is done by using openbable software which 
is open source software that helps us to convert from one 
format to another easily. 
 
c. Pubchem  
 
Pubchem is a free chemical database structures of 
small organic molecules and information on their biological 
activities hosted in NCBI web server. PubChem is organized 
as three linked databases within the NCBI's Entrez 
information retrieval system. These are PubChem Substance, 
PubChem Compound, and PubChem BioAssay. PubChem 
also provides a fast. 
 
9. GENETIC ALGORITHM IN AUTODOCK  
 
Genetic algorithms (GAs) are inspired in Darwin's 
theory of evaluation by natural selection and are powerful 
tool in difficult search and optimization problems [5]. 
Genetic Algorithm works with a population of individuals 
where each individual represents a possible solution for the 
problem .In the ligand-protein docking, a candidate solution 
specifies the position of the ligand with respect to the 
protein. Autodock uses a Lamarckian Genetic Algorithm to 
search for the optimal docking position of a ligand inside the 
protein [18]. Auto Dock represents the chromosome as a 
vector of real numbers as shown in figure 4. Each 
component in the vector stands for a gene. The individual 
chromosome has three genes representing the ligand 
translation, four genes representing the ligand orientation 
and the other genes represent the ligand conformation [19]. 
 
 Solution Space 
 
Auto Dock program intend to discover the optimal 
and best docked position of the ligand inside a 3D grid box 
specified in the active site of the receptor. The 3D grid box 
represents the solution space. The box is a continuous space 
and thus the total number of possible solutions is unlimited. 
Each 3D point inside this grid box is a potential candidate 
where the ligand can centered. 
 
 Genetic Code (Chromosome)  
 
Genetic algorithm usually identifies the notion of 
an individual and its genetic code (chromosome) with 
respect to the problems solution space [20]. The genetic 
code must uniquely identify a candidate solution. Auto Dock 
treats a particular orientation of ligand inside the protein as 
an “individual” in its GA. Hence, Auto Dock’s genetic code 
uniquely identifies the orientation of a ligand. Auto Dock 
represents the chromosome as a vector of real numbers. 
Each element in the vector stands for a gene. Pictorial 
representation of the chromosome can be found in the 
following figure. Following are used as genes contained in 
an individual’s chromosome. The following figure shows the 
representation of GA chromosome in the Auto Dock. 
 
Tx Ty Tz Qx Qy Qz Qw R1 Rn  
 
Fig 6: GA representation in AutoDock 
 
The Fig. 6 shows the parameters that used as genes 
contained in an individual’s chromosome. Translation genes 
(Tx, T y, Tz) specifying the center of ligand inside the 3D 
grid [18]. On the other hand, Quaternion genes (Qx, Qy, Qz, 
Qw) specifying the angles of’ N’ rotatable bounds in the 
ligand. 
 
 Genetic operation  
 
Autodock performs all the genetic operators 
namely, selection, crossover and mutation on the genetic 
code. 
 
 Fitness Evaluation(Energy Evaluation)  
 
Fitness evaluation (FE) evaluates the total energy of 
a particular orientation on the ligand inside the protein. 
Lower is better [18]. The energy evolution is used frequently 
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in AutoDock for every generation to recalculate the binding 
energy [19].   
 
10. PROTEIN PREPARATION IN ADT   
 
The crystal structure of falcipan-2 was retrieved 
from Protein Data Bank. The 3D coordinates used in this 
project are 2GHU.pdb. After retrieving the protein, save in 
the right directory with the collection of drugs. The next step 
is to read the molecular from the AutoDockTools (ADT) 
program and then remove all the water molecules and add 
the hydrogens to it. In addition, we have to make sure that 
the Kollman charges are added to the same protein.  
 
 
 
Fig 7: 3D structure of the target protein 
 
11. LIGAND PREPARATION IN ADT  
 
The candidate antimarlais were downloaded from 
pubchem database. They were obtained from a 
comprehensive literature survey.  The table below contains 
the pubChem ID, molecular weight, Hydrogen Bond Donor 
and Hydrogen Bond Acceptor. Basically, the format of the 
drugs in this database is on .sdf so, we have to convert it to 
.pdb. In order to do so, we used the openbabel application 
which helps us to reformat the drugs. 
 
a. Open babl  
 
It is free software, a chemical expert system mainly 
used for converting chemical file formats. Due to the strong 
relationship to informatics this program belongs more to the 
category cheminformatics than molecular modeling. It is a 
viable for windows, UNIX and Mac Os. [21]It is mainly 
used to convert from one format to another. For example, in 
our case, I want to convert from .sdf to .pdb. The following 
commend line should be executed in order to perform such 
conversion: 
 
 
 
In this case we chose the .pdb as our extension 
instead of .sdf which is obtained from pubchem database.    
After typing the above commend in Linux terminal, it will 
convert the sdf format to pdb which is readable in the 
autodock simulation.  
   
b. Grid File parementers in ADT 
 
After we have done the preparation for the target 
protein and the ligand now the task is to precalaculate these 
grids. In order to create the 3D box (grid) in which the 
protein molecule is enclosed we need to calculate the 
interaction of docking energy correctly and accurately. The 
grid box should be large enough to allow the drug to rotate 
freely inside the grid box, even when the ligand is in its most 
fully extended conformation. The parameters required to 
create such a grid are stored in the grid parameter file.gpf. In 
this experiments we used the 60X60X60 coordinates grids. 
Then, after that the autogrid4 run in the terminal to create a 
map for every atom type in the drug and create the 
corresponding macromolecular file with the following 
extension .glg 
 
autogrid4 –p file name.gpf –l filename.glg 
 
 
 
Fig 8: Grid Box used in the simulation 
 
12. DOCKING FILE PARAMETER IN ADT 
 
The primary goal of using docking parameter is to 
instruct Autodock about the ligand to move, the map files to 
use and some other properties that has been defined in the 
autogrid process. In the search methods about autodock, we 
select to work on genetic algorithm and we have set different 
value of crossover, mutation and population size to observe 
the results. Finally, we run the autodock4 in the terminal and 
it docked ligand files with the extension of .dlg which is 
docked ligand file. 
 
autodock4 –p filename.dpf –l filename.dlg 
 
13. EVALUATING DOCKING RESULTS     
 
Regardless of drug-protein docking programs has 
been used to conduct the simulation[22], docking algorithm 
parameters should be selected wisely in order to get the 
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appropriate dock to the ligand in the appropriate 
conformation in the active site. In order to validate the 
docking we checked the binding energy result which obtains 
by the following equation:  
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 This equation used to calculate the binding energy 
between protein and ligand in Autodock 4.0. The total 
binding energy is composed of  
 
• ΔGvdw : van der Waals 
• ΔGH-Bound: Hydrogen Bonding 
• ΔGelec: Electrostatics  
• ΔGdesolv: Desolvation 
• ΔGtor = Wtor Ntor 
 
So the above are the weight for the respective terms.  
 
• Aij, Bij, Cij, Dij are atom type pair specific terms. 
• rij: is the interatomic distance. 
• E (t): correspond to a directional weight based on 
the angle t between the probe and the target atom. 
(That gives H-Bond term the character of 
“directional”). 
• Ntor : is the number of rotatable bonds. 
• Si and VI are salvation parameters. 
•  is a distance weighting function set to 3.5 A   
• qi and qj are point charges on atoms i and j. 
• ε(r) is dielectric constant.  
 
14. EXPERIMENTAL RESULTS   
 
The molecular docking study was performed on 
protein target name falcipain-2 (2GHU.pdb) and a set of 20 
Drugs retrieved from pubchem database. The experiment 
was conducted in three different cases with three different 
workstations. In the first case we used the default parameters 
then in the next case we used the parametric study proposed 
in [23] to select the best drug candidate. Finally, we 
conducted the experiment to calculate the required docking 
time to finish one simulation. The results shows drug 
Dioncopeltine A has the lowest binding energy which is -
8.64 Kcal/mol. Thus, it selected as the best candidate drug 
design in the experiment.   
 
 
 
 
• Lipinski’s rule of five 
 
The following properties are essential for good permeation 
 
1) The molecule has less than five proton-donators. 
(HBD<5). 
2) The molecular weight is smaller than 500 Dalton 
(MW<500). 
3) log P smaller than 5(log p<5). 
4) The molecule has less acceptors than 10 
(HBA<10). 
 
CASE 1:   
 
 In the first case we performed the simulation [24] in 
all the   compounds (drugs) with the default parameters as in 
table 2. 
 
Table 2: Auto Dock parameters and processing data 
 
Parameters Value 
Maximum Number of GA runs 10 
Population size 150 
Maximum number of evaluation 250000 
Rate of Gene mutation 0.02 
Rate of Crossover   0.8 
 
 We performed the experiment in single workstation 
AMD phenom™ 9600B Quad-core processor (2.3 GHz) 
with 2 GB memory size.  The implementation is done using 
AutoDock simulation tool. Also, we concern about the time 
consuming in running of each simulation. While we 
conducting the experiments we got different time based on 
the parameters chosen.   Table 3 table contains the binding 
energy for each drug. As we said early, the best binding 
energy is the lowest. 
 
Table 3:  Binding Energy results 
 
Drug Name Pubchem ID Binding 
Energy2 
Amodiaquine 2165 -8.08 
Artemether 456408 -7.68 
Artemisinine 68827 -7.71 
Artesunate 65664 -7.12 
Atovaquone 74989 -7.68 
Chloroquine 2719 -7.53 
Dapsone 2955 -6.07 
dihydroquinghaosu 107770 -7.63 
Dioncopeltine A 185971 -8.64 
                                                 
2 Since the value of binding energy is negative so the graph is appear like 
that. 
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Hydroxychloroquine 3652 -7.2 
lumefantrine 6437380 -9.48 
Mefloquine 4046 -7.01 
minquartynoic acid 183614 -4.53 
Primaquine 4908 -7.62 
proguanil 6178111 -9 
Pyrimethamine 4993 -7.26 
Quinacrine 237 -8.05 
Quinidine 441074 -7.93 
Quinine 8549 -8.45 
Sulfadoxine 17134 -6.58 
 
 
 
Fig 9: Binding Energy Diagram. 
 
 Based on fig.9, lumefantrine drug has the highest 
binding energy which is consider as the lowest binding 
energy. But based on Lipinski’s rule of five, it cannot be 
selected as drug candidate for our experiment because log p 
value is 8.7 which is higher than 5 as stated in the rule. So, 
we have to search for another drug that satisfies the 
conditions. 
 
 
 
Fig 10: log p values for various drugs  
 
 As we can see from fig.10, the drug Dioncopeltine 
A satisfies the requirements. The lowest binding energy was 
around the -8.64 Kcal/mol with log p value is 3.4 which is 
less than 5 .hence; it satisfies the Lipinski’s rule of five. 
 
CASE 2: 
 
 In this case, we preformed the method which 
proposed in [23].  The main aims of this method were to 
study the performance of the genetic algorithm (GA) in the 
selected drugs. Since we have 20 selected drugs for the 
malaria with protein target, the parametric study used to find 
the suitable set of parameters. We conducted experiment of 
480 samples with different probabilities of population size, 
crossover rate and mutation rate. The population size set 
from 50,100,150 and probability of crossover set from 0.2, 
0.4, 0.6, and 0.8.  Finally, the mutation rate set to 0.01 and 
0.02. Table 4 show the results obtained from the experiment. 
 
Table 4: Results of Parametric study 
 
 
       
 
 
Fig 11: molecular Weight values for drug candidates  
 
 
Based fig.11, we found that, drug lumefantrine has 
the height molecular weight among the drug candidates. 
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From table 4, we conclude that the drug Dioncopeltine A has 
the lowest binding energy from the docking simulation 
which is -8.64Kcal/mol. The result is shown in table 4   
which is partial result. Among the 480 samples we selected 
the best drugs with lowest binding energy. In table 4, we 
summarize the results and it shows that the best binding 
energy was with population size of 100, crossover rate 0.2 
and mutation rate is 0.01.  
 
The expected output is illustrated in fig.11. 
However, the fig.9 shows the lowest binding energy based in 
the first run, but since the lumefantrine drug does not follow 
the Lipinski’s rule of five with the value of log p 8.7 which 
is greater than 5. So, we have to search for the alternative 
candidate which is Dioncopeltine A with the value of -8.64 
Kcal/mol. 
 
 
Fig 12: docking file result 
 
Fig.12 demonstrates the partial results obtained 
from the docking simulation. The first column is the cluster 
rank which shows the point where the lignd docked into the 
best conformation with the protein active site. The second 
column is lowest binding energy. We took this parameter as 
standard criteria to show the best drug fit with the protein. 
Usually, the lowest binding energy is the best candidate 
drug. The mean binding energy is the parameter used to find 
the critical point between two values. Number in cluster 
showed how many clusters are in this conformation and 
finally the histogram column which shows the visualize the 
experiments. 
 
CASE 3:  
 
In this case, we attempted to calculate the time 
required to perform the docking for each drugs (ligand). We 
investigate the central processing unit (CPU) time required 
for completing a docking attempt on docking simulation.  
Table 10 shows the docking time spent to perform single 
docking simulation: 
 
Table 5: Docking times for ligand 
 
 
 
 
 
Fig 13: The docking time for drugs 
 
From fig.13, we can conclude that, drug 
lumefantrine required some times to perform the docking 
simulation due to the molecular weight. So there a great 
impact of the molecular weight in the molecular docking 
simulation.  The time required to do this docking is 
approximately 14 minutes. To overcome such delay in the 
experiment some researcher proposed some mechanism as 
discussed in [25]. They proposed the use of grid computing 
in this simulation that will help to perform more than one 
simulation in same computers and in parallel.             
 
15. CONCLUSION AND FUTURE WORK  
 
 In conclusion, designing drugs through the rational 
drug design (RDD) reduce the time require to conduct the 
experiment in the laboratory. In addition, computational 
molecular docking. In fact, this project discussed the usage 
of genetic algorithm (GA) as crucial tool in the rational drug 
design. It is clear that using the computational techniques in 
molecular docking helps the scientists and the researchers to 
simulate their experiments easily and rapidly. Moreover, we 
found that, from the experiment that there are so many 
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antimalaria drugs are in the market but choosing the 
effective and efficient among them is still the problems. By 
using autodock docking simulation we hope that will 
overcome such issues. The Protein-Ligand interaction plays 
a significant role in structural based drug designing. In this 
project, we performed the experiment in Malaria as our 
target disease using the Genetic Algorithm tools as main 
approach. The receptor Plasmodium falciparum which is the 
most dangerous and widespread disease-causing species has 
been selected for further investigation. In addition, falcipain-
2(FP-2) of p. Flaciparum is a protein-family that plays an 
important role in the parasite life cycle. Also, I identified the 
drugs that were used against Malaria Disease. When the 
receptor (2GHU) was docked with the 20 selected drugs, the 
results from molecular docking simulation indicate that drug 
Diocopeltine A was found as the best lowest binding energy 
with the value of -8.64 Kcal/mol and crossover rate was 
around 0.2, mutation rate was 0.01 and population size was 
around 100. Thus, it can be selected as the anti marlia drug 
candidate. 
 
 Finally, for the future work, further investigations 
on selected drugs and in vivo studies are necessary to 
develop potential chemical entities with the help of genetic 
algorithm tools in the computational molecular docking. In 
addition, I do propose the use of serial processing which 
sequentially solve each piece of a problem on block beside 
use the grid computing in the future work. 
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